Trial Profile
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Pharmacodynamics
- Acronyms BONAFIDE
- Sponsors Amgen
- 29 May 2014 New trial record
- 25 Aug 2011
- 03 Mar 2006